Avenue Therapeutics Inc. (ATXI) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Avenue Therapeutics Inc. (ATXI:NASDAQ), powered by AI.

Current Price
$0.30
P/E Ratio
-0.3
Market Cap
939,339
Sector
Healthcare
What is the Avenue Therapeutics Inc. stock price forecast?

Avenue Therapeutics Inc. is currently trading at $0.30. View real-time AI analysis on Alpha Lenz.

What is Avenue Therapeutics Inc. insider trading activity?

View the latest insider trading data for Avenue Therapeutics Inc. on Alpha Lenz.

What is Avenue Therapeutics Inc.'s P/E ratio?

Avenue Therapeutics Inc.'s P/E ratio is -0.3.

Avenue Therapeutics Inc.

NASDAQ · ATXI
$0.30+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Avenue Therapeutics Inc.'s future dividend policy...
Alpha Chat Insight

Avenue Therapeutics Inc. trades at a P/E of -0.3 (undervalued) with modest ROE of -125.7%.

Ask for details

Company Overview

Avenue Therapeutics Inc. is a biopharmaceutical company engaged in the development and commercialization of novel therapies for the treatment of pain. The company's primary focus lies in creating solutions for post-operative pain relief through innovative pharmaceutical products. Avenue Therapeutics specializes in leveraging opioid analgesic drugs, aiming to improve patient outcomes in controlled medical settings. Its operations primarily intersect the healthcare and pharmaceutical industries, catering to medical institutions, healthcare providers, and patients requiring effective pain management solutions. With its commitment to addressing unmet medical needs, Avenue Therapeutics plays a critical role in enhancing pain treatment regimens and expanding therapeutic options available to healthcare professionals, contributing to advancements in patient care and wellbeing within the medical community.

CEODr. Alexandra MacLean M.D.
SectorHealthcare
IndustryBiotechnology
Employees2

Company Statistics

FY 2025

Profile

$939.34KMarket Cap
$1.40MRevenue
0.00Shares Out
2Employees

Margins

N/AGross
-249.57%EBITDA
-234.05%Operating
-209.90%Pre-Tax
-209.90%Net

Valuation

-0.32P/E
0.51P/B
0.67EV/Sales
0.55EV/EBITDA
-0.51P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-105.19%ROA
-125.69%ROE
-117.29%ROIC

Financial Health

$2.85MCash & Cash Equivalents
$-1.76MNet Debt
59.99%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Avenue Therapeutics Inc. (ticker: ATXI) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 2 employees. Market cap is $939,339.

The current price is $0.3 with a P/E ratio of -0.32x and P/B of 0.51x.

ROE is -125.69% and operating margin is -234.05%. Annual revenue is $1M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Avenue Therapeutics Inc. (ATXI) Stock Forecast 2026 $0.30 — Price, Financials & Analyst Targets | Alpha Lenz